Article

Serological Response to SARS-CoV-2 after COVID-19 Vaccination in Lung Cancer patients: Short Review

2023-04-04

Abstract excerpt

In comparison to the general population, lung cancer patients are more likely to suffer from severe Coronavirus disease (COVID-19) and mortality associated with it. Considering this increased risk, and in order to prevent symptoms and severe disease, patients with lung cancer have been prioritized for COVID-19 vaccinations, primary and booster doses. Despite this, the pivotal clinical trials did not include these...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: 2ad68905-1354-5e9d-8f4c-aa8c864a2072
DOI: 10.20944/preprints202304.0038.v1

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Serological Response to SARS-CoV-2 after COVID-19 Vaccination in Lung Cancer patients: Short ReviewDOI 10.20944/preprints202304.0038.v1Read

Antibody Responses to SARS-CoV-2 Infection in Cancer PatientsSemantic proximity Read

Interim results of the safety and immune-efficacy of 1 versus 2 doses of COVID-19 vaccine BNT162b2 for cancer patients in the context of the UK vaccine priority guidelinesSemantic proximity Read

Adaptive immunity and neutralizing antibodies against SARS-CoV-2 variants of concern following vaccination in patients with cancer: The CAPTURE studySemantic proximity Read

Immune responses following third COVID-19 vaccination are reduced in patients with hematologic malignancies compared to patients with solid cancerSemantic proximity Read

COVID-19–Sensitive Tumour Response – 2-Year Assessment of the SARS-CoV-2 Humoral Response in Cancer Patients in Oncology Hospital in PolandSemantic proximity Read

MicroRNAs immune response profile to COVID-19 vaccine boost in cancer patients under active treatmentSemantic proximity Read

Effect of mRNA vaccination on pulmonary sequelae after mild COVID-19Semantic proximity Read

Efficacy of SARS-CoV-2 primary and booster vaccine doses in CAR-T recipientsSemantic proximity Read

Antibody response to SARS-CoV-2 mRNA vaccine in lung cancer patients: Reactivity to vaccine antigen and variants of concernSemantic proximity Read

Impaired neutralizing antibody response to COVID-19 mRNA vaccines in cancer patientsSemantic proximity Read

Unveiling Humoral and Cellular Immune Responses to SARS-CoV-2 in Head and Neck Cancer: A Comparative Study of Vaccination and Natural Infection in RomaniaSemantic proximity Read

Long-term respiratory mucosal immune memory to SARS-CoV-2 after infection and vaccinationSemantic proximity Read